Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LMP1' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 181 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Liu, Y; Wang, XH; Lo, AKF; Wong, YC; Cheung, ALM; Tsao, SW
      Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells

      JOURNAL OF MEDICAL VIROLOGY
    2. Higuchi, M; Kieff, E; Izumi, KM
      The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines

      JOURNAL OF VIROLOGY
    3. Yoshizaki, T; Horikawa, T; Ren, QC; Wakisaka, N; Takeshita, H; Sheen, TS; Lee, SY; Sato, H; Furukawa, M
      Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1and its correlation to angiogenesis in nasopharyngeal carcinoma

      CLINICAL CANCER RESEARCH
    4. Eliopoulos, AG; Young, LS
      LMP1 structure and signal transduction

      SEMINARS IN CANCER BIOLOGY
    5. Lin, SY; Tsang, NM; Kao, SC; Hsieh, YL; Chen, YP; Tsai, CS; Kuo, TT; Hao, SP; Chen, IH; Hong, JH
      Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    6. Lee, IS; Shin, YK; Chung, DH; Park, SH
      LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells

      LEUKEMIA & LYMPHOMA
    7. Santon, A; Bellas, C
      Deletions within the Epstein-Barr virus latent membrane protein-1 oncogenein adult ordinary, HIV-associated and paediatric Hodgkin's disease

      LEUKEMIA & LYMPHOMA
    8. Wang, F; Rivailler, P; Rao, P; Cho, YG
      Simian homologues of Epstein-Barr virus

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    9. Coffin, WF; Erickson, KD; Hoedt-Miller, M; Martin, JM
      The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain

      ONCOGENE
    10. Hiraki, A; Fujii, N; Masuda, K; Ikeda, K; Tanimoto, M
      Genetics of Epstein-Barr virus infection

      BIOMEDICINE & PHARMACOTHERAPY
    11. Schultheiss, U; Puschner, S; Kremmer, E; Mak, TW; Hammerschmidt, W; Kieser, A
      TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1

      EMBO JOURNAL
    12. Kaykas, A; Worringer, K; Sugden, B
      CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex

      EMBO JOURNAL
    13. Kuo, TT; Tsang, NM
      Salivary gland type nasopharyngeal carcinoma - A histologic, immunohistochemical, and Epstein-Barr virus study of 15 cases including a psammomatous mucoepidermoid carcinoma

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    14. Blaschke, S; Hannig, H; Buske, C; Kaup, FJ; Hunsmann, G; Bodemer, W
      Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques

      JOURNAL OF MEDICAL VIROLOGY
    15. Dawson, CW; George, JH; Blake, SMS; Longnecker, R; Young, LS
      The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1

      VIROLOGY
    16. Blake, SMS; Eliopoulos, AG; Dawson, CW; Young, LS
      The transmembrane domains of the EBV-Encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity

      VIROLOGY
    17. Vockerodt, M; Haier, B; Buttgereit, P; Tesch, H; Kube, D
      The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 inBurkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway

      VIROLOGY
    18. Schafer, H; Berger, C; Aepinus, C; Hebart, H; Beck, R; Kaiserling, E; Kanz, L; Einsele, H; Knecht, H
      Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: New insights through latent membrane protein 1 fingerprinting

      TRANSPLANTATION
    19. Knecht, H; Berger, C; Rothenberger, S; Odermatt, BF; Brousset, P
      The role of Epstein-Barr virus in neoplastic transformation

      ONCOLOGY
    20. Cho, YG; Ramer, J; Rivailler, P; Quink, C; Garber, RL; Beier, DR; Wang, F
      An Epstein-Barr-related herpesvirus from marmoset lymphomas

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    21. Zhang, LW; Wu, LH; Hong, K; Pagano, JS
      Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7

      JOURNAL OF VIROLOGY
    22. Shirakata, M; Imadome, KI; Okazaki, K; Hirai, K
      Activation of TRAF5 and TRAF6 signal cascades negatively regulates the latent replication origin of Epstein-Barr virus through p38 mitogen-activated protein kinase

      JOURNAL OF VIROLOGY
    23. Zhang, LW; Pagano, JS
      Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1

      JOURNAL OF VIROLOGY
    24. Murray, PG; Flavell, JR; Baumforth, KRN; Toomey, SM; Lowe, D; Crocker, J; Ambinder, RF; Young, LS
      Expression of the tumour necrosis factor receptor-associated factors 1 and2 in Hodgkin's disease

      JOURNAL OF PATHOLOGY
    25. Yamada, M; Shiroko, T; Kawaguchi, Y; Sugiyama, Y; Egilmez, NK; Chen, FA; Bankert, RB
      CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors

      INTERNATIONAL JOURNAL OF CANCER
    26. Hahn, P; Novikova, E; Scherback, L; Janik, C; Pavlish, O; Arkhipov, V; Nicholls, J; Muller-Lantzsch, N; Gurtsevitch, V; Grasser, FA
      The LMP1 gene isolated from Russian nasopharyngeal carcinoma has no 30-bp deletion

      INTERNATIONAL JOURNAL OF CANCER
    27. Henry, S; Sacaze, C; Berrajah, L; Karray, H; Drira, M; Hammami, A; Icart, J; Mariame, B
      In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different Epstein-Barr virus strains

      INTERNATIONAL JOURNAL OF CANCER
    28. Kenney, JL; Guinness, ME; Reiss, M; Lacy, J
      Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents

      INTERNATIONAL JOURNAL OF CANCER
    29. Noguchi, T; Ikeda, K; Yamamoto, K; Yoshida, I; Ashiba, A; Tsuchiyama, J; Shinagawa, K; Yoshino, T; Takata, M; Harada, M
      Antisense oligodeoxynucleotides to latent membrane protein 1 induce growthinhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells

      BRITISH JOURNAL OF HAEMATOLOGY
    30. Lee, IS; Kim, MK; Choi, EY; Mehl, A; Jung, KC; Gil, MC; Rowe, M; Park, SH
      CD99 expression is positively regulated by Sp1 and is negatively regulatedby Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappa B

      BLOOD
    31. Horikawa, T; Sheen, TS; Takeshita, H; Sato, H; Furukawa, M; Yoshizaki, T
      Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma

      AMERICAN JOURNAL OF PATHOLOGY
    32. D'Addario, M; Chauvin, P
      Ethnic differences in the expression of Epstein-Barr virus latent membraneprotein-1 mutations in nasopharyngeal carcinoma

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    33. Flavell, JR; Baumforth, KRN; Williams, DM; Lukesova, M; Madarova, J; Noskova, V; Prochazkova, J; Lowe, D; Kolar, Z; Murray, PG; Nelson, PN
      Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    34. Kurth, J; Spieker, T; Wustrow, J; Strickler, JG; Hansmann, ML; Rajewsky, K; Kuppers, R
      EBV-infected B cells in infectious mononucleosis: Viral strategies for spreading in the B cell compartment and establishing latency

      IMMUNITY
    35. Montalban, C; Abraira, V; Morente, M; Acevedo, A; Aguilera, B; Bellas, C; Fraga, M; Del Moral, RG; Menarguez, J; Oliva, H; Sanchez-Beato, M; Piris, MA
      Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy

      LEUKEMIA & LYMPHOMA
    36. Tabata, Y; Hibi, S; Teramura, T; Kuriyama, K; Yagi, T; Todo, S; Sawada, T; Imashuku, S
      Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan

      LEUKEMIA & LYMPHOMA
    37. Rickinson, AB; Lane, PJL
      Epstein-Barr virus: Co-opting B-cell memory and migration

      CURRENT BIOLOGY
    38. Yang, XH; He, ZM; Xin, BZ; Cao, L
      LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16(INK4a) expression

      ONCOGENE
    39. Kim, KR; Yoshizaki, T; Miyamori, H; Hasegawa, K; Horikawa, T; Furukawa, M; Harada, S; Seiki, M; Sato, H
      Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1and invasive growth

      ONCOGENE
    40. Bertalot, G; Biasi, MO; Gramegna, M; Askaa, J; Dell'Orto, P; Viale, G
      Immunoreactivity for latent membrane protein 1 of Epstein-Barr virus in nevi and melanomas is not related to the viral infection

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    41. Komi, J; Lassila, O
      Toremifene increases the expression of intercellular adhesion molecule-1 (ICAM-1) on MCF-7 breast cancer cells and Jurkat cells

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    42. Wade, M; Allday, MJ
      Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins

      MOLECULAR AND CELLULAR BIOLOGY
    43. Eliopoulos, AG; Davies, C; Knox, PG; Gallagher, NJ; Afford, SC; Adams, DH; Young, LS
      CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily

      MOLECULAR AND CELLULAR BIOLOGY
    44. Laytragoon-Lewin, N; Porwit-Macdonald, A; Mellstedt, H; Lewin, F
      Alteration of cellular mediated cytotoxicity, T cell receptor zeta (TcR zeta) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC)patients: Possible clinical relevance

      ANTICANCER RESEARCH
    45. Kleines, M; Finke, K; Ritter, K; Schaade, L
      Induction of growth rate and transcriptional modulation of growth promoters and growth inhibitors in epithelial cells by EBV-LMP1

      VIRUS RESEARCH
    46. Chien, ML; Hammarskjold, ML
      Epstein-Barr virus latent membrane protein (LMP1) induces specific NF kappa B complexes in human T-lymphoid cells

      VIRUS RESEARCH
    47. Meij, P; Vervoort, MBHJ; Meijer, CJLM; Bloemena, E; Middeldorp, JM
      Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells

      JOURNAL OF VIROLOGICAL METHODS
    48. Xu, ZG; Iwatsuki, K; Ohtsuka, M; Oyama, N; Matsui, T; Kaneko, F
      Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan

      JOURNAL OF MEDICAL VIROLOGY
    49. Trivedi, P; Cuomo, L; Christensson, B; Hu, LF; Morrone, S; Frati, L; Faggioni, A; Winberg, G; Klein, G
      Augmentation of leukocyte infiltration in murine tumors expressing B-cell derived but not nasopharyngeal carcinoma derived EBV membrane protein LMP1

      JOURNAL OF MEDICAL VIROLOGY
    50. Ehsan, A; Fan, HX; Eagan, PA; Siddiqui, HA; Gulley, ML
      Accumulation of p53 in infectious mononucleosis tissues

      HUMAN PATHOLOGY
    51. Tsukamoto, K; Hayakawa, H; Sato, A; Chida, K; Nakamura, H; Miura, K
      Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis

      THORAX
    52. Ni, CZ; Welsh, K; Leo, E; Chiou, CK; Wu, H; Reed, JC; Ely, KR
      Molecular basis for CD40 signaling mediated by TRAF3

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    53. Sandberg, ML; Kaykas, A; Sugden, B
      Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression

      JOURNAL OF VIROLOGY
    54. Choi, JK; Ishido, S; Jung, JU
      The collagen repeat sequence is a determinant of the degree of herpesvirussaimiri STP transforming activity

      JOURNAL OF VIROLOGY
    55. Webster-Cyriaque, J; Middeldorp, J; Raab-Traub, N
      Hairy leukoplakia: Arm unusual combination of transforming and permissive Epstein-Barr virus infections

      JOURNAL OF VIROLOGY
    56. Xu, JW; Ahmad, A; D'Addario, M; Knafo, L; Jones, JF; Prasad, U; Dolcetti, R; Vaccher, E; Menezes, J
      Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases

      JOURNAL OF IMMUNOLOGY
    57. He, ZM; Xin, BZ; Yang, XH; Chan, CP; Cao, L
      Nuclear factor-kappa B activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts

      CANCER RESEARCH
    58. Kennedy, MM; Biddolph, S; Lucas, SB; Howells, DD; Picton, S; McGee, JO; O'Leary, JJ
      CD40 upregulation is independent of HHV-8 in the pathogenesis of Kaposi's sarcoma

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    59. Oshima, M; Azuma, H; Okuno, A
      High prevalence of Epstein-Barr virus type A strain with the 30 b.p. deletion of the latent membrane protein-1 gene in a Japanese population

      PEDIATRICS INTERNATIONAL
    60. Knecht, H; Berger, C; McQuain, C; Rothenberger, S; Bachmann, E; Martin, J; Esslinger, C; Drexler, HG; Cai, YC; Quesenberry, PJ; Odermatt, BF
      Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease

      ONCOGENE
    61. McFarland, EDC; Izumi, KM; Mosialos, G
      Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappa B

      ONCOGENE
    62. Mitterer, M; Pescosta, N; Mc Quain, C; Gebert, U; Oberkofler, E; Coser, P; Knecht, H
      Epstein-Barr virus related hemophagocytic syndrome in a T-cell rich B-celllymphoma

      ANNALS OF ONCOLOGY
    63. Sheen, TS; Huang, YT; Chang, YL; Ko, JY; Wu, CS; Yu, YC; Tsai, CH; Hsu, MM
      Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma

      JAPANESE JOURNAL OF CANCER RESEARCH
    64. Ohshima, K; Suzumiya, J; Kanda, M; Haraoka, S; Kawasaki, C; Shimazaki, K; Kikuchi, M
      Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma

      HISTOPATHOLOGY
    65. Young, LS; Dawson, CW; Eliopoulos, AG
      Epstein-Barr virus and apoptosis: viral mimicry of cellular pathways

      BIOCHEMICAL SOCIETY TRANSACTIONS
    66. Izumi, KM; McFarland, EC; Ting, AT; Riley, EA; Seed, B; Kieff, ED
      The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappa B activation

      MOLECULAR AND CELLULAR BIOLOGY
    67. Gires, O; Kohlhuber, F; Kilger, E; Baumann, M; Kieser, A; Kaiser, C; Zeidler, R; Scheffer, B; Ueffing, M; Hammerschmidt, W
      Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

      EMBO JOURNAL
    68. Fischer, N; Kopper, B; Graf, N; Schlehofer, JR; Grasser, FA; Mueller-Lantzsch, N
      Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers

      VIRUS RESEARCH
    69. Mori, S; Itoh, T; Tokunaga, M; Eizuru, Y
      Deletions and single-base mutations within the carboxy-terminal region of the latent membrane protein 1 oncogene in Epstein-Barr virus-related gastric cancers of southern Japan

      JOURNAL OF MEDICAL VIROLOGY
    70. Dirnhofer, S; Angeles-Angeles, A; Ortiz-Hidalgo, C; Reyes, E; Gredler, E; Krugmann, J; Fend, F; Quintanilla-Martinez, L
      High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV)latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue

      HUMAN PATHOLOGY
    71. Tsai, CN; Lee, CM; Chien, CK; Kuo, SC; Chang, YS
      Additive effect of Sp1 and Sp3 in regulation of the ED-L1E promoter of theEBV LMP 1 gene in human epithelial cells

      VIROLOGY
    72. Edwards, RH; Seillier-Moiseiwitsch, F; Raab-Traub, N
      Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains

      VIROLOGY
    73. Eliopoulos, AG; Blake, SMS; Floettmann, JE; Rowe, M; Young, LS
      Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2

      JOURNAL OF VIROLOGY
    74. Fenton, M; Sinclair, AJ
      Divergent requirements for the MAPK(ERK) signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters

      JOURNAL OF VIROLOGY
    75. Codd, JD; Salisbury, JR; Packham, G; Nicholson, LJ
      A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma

      JOURNAL OF PATHOLOGY
    76. Meij, P; Vervoort, MBHJ; Aarbiou, J; van Dissel, P; Brink, A; Bloemena, E; Meijer, CJLM; Middeldorp, JM
      Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases

      JOURNAL OF INFECTIOUS DISEASES
    77. Walling, DM; Shebib, N; Weaver, SC; Nichols, CM; Flaitz, CM; Webster-Cyriaque, J
      The molecular epidemiology and evolution of Epstein-Barr virus: Sequence variation and genetic recombination in the latent membrane protein-1 gene

      JOURNAL OF INFECTIOUS DISEASES
    78. Berger, C; van Baarle, D; Kersten, MJ; Klein, MR; Al-Homsi, AS; Dunn, B; McQuain, C; van Oers, R; Knecht, H
      Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: Reliable markers for individual strain identification

      JOURNAL OF INFECTIOUS DISEASES
    79. Kuzushima, K; Nakamura, S; Nakamura, T; Yamamura, Y; Yokoyama, N; Fujita, M; Kiyono, T; Tsurumi, T
      Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma

      JOURNAL OF CLINICAL INVESTIGATION
    80. Becker, JL; Miller, F; Nuovo, GJ; Josepovitz, C; Schubach, WH; Nord, EP
      Epstein-Barr virus infection of renal proximal tubule cells: possible rolein chronic interstitial nephritis

      JOURNAL OF CLINICAL INVESTIGATION
    81. Puls, A; Eliopoulos, AG; Nobes, CD; Bridges, T; Young, LS; Hall, A
      Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF alpha and IL-1, and by the Epstein-Barr virus transforming protein LMP1

      JOURNAL OF CELL SCIENCE
    82. Ardila-Osorio, H; Clausse, B; Mishal, Z; Wiels, J; Tursz, T; Busson, P
      Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes oflymphoblastoid and nasopharyngeal carcinoma cells

      INTERNATIONAL JOURNAL OF CANCER
    83. Dolcetti, R; Quaia, M; Gloghini, A; De Re, V; Zancai, P; Cariati, R; Babuin, L; Cilia, AM; Rizzo, S; Carbone, A; Boiocchi, M
      Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease

      INTERNATIONAL JOURNAL OF CANCER
    84. Huang, YT; Sheen, TS; Chen, CL; Lu, J; Chang, Y; Chen, JY; Tsai, CH
      Profile of cytokine expression in nasopharyngeal carcinomas: A distinct expression of interleukin 1 in tumor and CD4(+) T cells

      CANCER RESEARCH
    85. Sbih-Lammali, F; Clausse, B; Ardila-Osorio, H; Guerry, R; Talbot, M; Havouis, S; Ferradini, L; Bosq, J; Tursz, T; Busson, P
      Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: Opposite effects of CD95 and CD40 stimulation

      CANCER RESEARCH
    86. Farwell, DG; McDougall, JK; Coltrera, MD
      Expression of Epstein-Barr virus latent membrane proteins leads to changesin keratinocyte cell adhesion

      ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
    87. SIBILIA J; LIOTE F; MARIETTE X
      LYMPHOPROLIFERATIVE DISORDERS IN RHEUMATOID-ARTHRITIS PATIENTS ON LOW-DOSE METHOTREXATE

      Revue du rhumatisme
    88. ALHOMSI AS; BERGER C; VANBAARLE D; KERSTEN MJ; KLEIN MR; MCQUAIN C; VANOERS R; KNECHT H
      MOLECULAR ANALYSIS OF CRITICAL SEQUENCES WITHIN THE EBNA-2 TYPE-1 GENE FROM EPSTEIN-BARR-VIRUS ISOLATES FROM PATIENTS WITH INFECTIOUS-MONONUCLEOSIS, TONSILLAR HYPERPLASIA, AND HIV-INFECTION

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    89. KERSTEN MJ; VANGORP J; PALS ST; BOON F; VANOERS MHJ
      EXPRESSION OF EPSTEIN-BARR-VIRUS LATENT GENES AND ADHESION MOLECULES IN AIDS-RELATED NON-HODGKINS-LYMPHOMAS - CORRELATION WITH HISTOLOGY AND CD4-CELL NUMBER

      Leukemia & lymphoma
    90. WU CJ; LEU CY; LIU ST; CHOW KP; MENG CL; CHANG YS
      TRANSCRIPTIONAL ACTIVATION OF NF-KAPPA-B ACTIVITY BY EPSTEIN-BARR-VIRUS (EBV) LMP1 AS A SELECTIVE THERAPEUTIC STRATEGY FOR EBV-ASSOCIATED DISEASES

      Gene therapy
    91. MILLER WE; CHESHIRE JL; BALDWIN AS; RAABTRAUB N
      THE NPC DERIVED C15 LMP1 PROTEIN CONFERS ENHANCED ACTIVATION OF NF-KAPPA-B AND INDUCTION OF THE EGFR IN EPITHELIAL-CELLS

      Oncogene
    92. ELIOPOULOS AG; YOUNG LS
      ACTIVATION OF THE CJUN N-TERMINAL KINASE (JNK) PATHWAY BY THE EPSTEIN-BARR-VIRUS-ENCODED LATENT MEMBRANE-PROTEIN-1 (LMP1)

      Oncogene
    93. TAJIMA M; KOMURO M; OKINAGA K
      ESTABLISHMENT OF EPSTEIN-BARR VIRUS-POSITIVE HUMAN GASTRIC EPITHELIAL-CELL LINES

      Japanese journal of cancer research
    94. ELENITOBAJOHNSON KSJ; ZARATEOSORNO A; MENESES A; KRENACS L; KINGMA DW; RAFFELD M; JAFFE ES
      CYTOTOXIC GRANULAR PROTEIN EXPRESSION, EPSTEIN-BARR-VIRUS STRAIN TYPE, AND LATENT MEMBRANE PROTEIN-1 ONCOGENE DELETIONS IN NASAL T-LYMPHOCYTE NATURAL-KILLER-CELL LYMPHOMAS FROM MEXICO

      Modern pathology
    95. QUINTANILLAMARTINEZ L; LOMEMALDONADO C; SCHWARZMANN F; GREDLER E; REYES E; ANGELESANGELES A; FEND F
      POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS IN MEXICO - AN AGGRESSIVE CLONAL DISEASE-ASSOCIATED WITH EPSTEIN-BARR-VIRUS TYPE-A

      Modern pathology
    96. GRIFFIN BE; XUE SA
      EPSTEIN-BARR-VIRUS INFECTIONS AND THEIR ASSOCIATION WITH HUMAN MALIGNANCIES - SOME KEY QUESTIONS

      Annals of medicine
    97. KILGER E; KIESER A; BAUMANN M; HAMMERSCHMIDT W
      EPSTEIN-BARR VIRUS-MEDIATED B-CELL PROLIFERATION IS DEPENDENT UPON LATENT MEMBRANE-PROTEIN-1, WHICH SIMULATES AN ACTIVATED CD40 RECEPTOR

      EMBO journal
    98. YOUNG LS; ELIOPOULOS AG; GALLAGHER NJ; DAWSON CW
      CD40 AND EPITHELIAL-CELLS - ACROSS THE GREAT DIVIDE

      Immunology today
    99. BEATTY PR; KRAMS SM; ESQUIVEL CO; MARTINEZ OM
      EFFECT OF CYCLOSPORINE AND TACROLIMUS ON THE GROWTH OF EPSTEIN-BARR VIRUS-TRANSFORMED B-CELL LINES

      Transplantation
    100. LIEBOWITZ D
      EPSTEIN-BARR-VIRUS AND A CELLULAR SIGNALING PATHWAY IN LYMPHOMAS FROMIMMUNOSUPPRESSED PATIENTS

      The New England journal of medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 09:46:36